Updated:
NuevaBio
NuevaBio is an investment company based in Palo Alto, California. Founded in 2022, it invests in biotech sector companies. NuevaBio has made two investments,...
NuevaBio
NuevaBio is an investment company based in Palo Alto, California. Founded in 2022, it invests in biotech sector companies. NuevaBio has made two investments, including OrsoBio in a Series B round on September 06, 2024.
General information
Firm type
Private Equity
Year founded
2022
Location
Region
North America
Country
United States
City
Palo Alto
Corporate office
Palo Alto, United States
Principals
Mani Subramanian
Founder
Manoj Desai
Founder
Gans Ganapati
Founder
Sector focus
Frequently asked questions
Does NuevaBio participate in fund commitments or only direct deals?
The firm's investment vehicle structure is not disclosed. Based on its early-stage focus and small team profile, NuevaBio is expected to make direct equity investments into portfolio companies rather than acting as a fund-of-funds allocator.
Which sectors does NuevaBio actively invest in?
NuevaBio invests in biotechnology and life sciences broadly, encompassing therapeutics, diagnostics, and medical devices. The firm has not published a list of excluded sub-sectors, though its seed-stage orientation naturally precludes service-based healthcare or late-stage commercial assets.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: